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Abstract
Objective: Hyperinsulinemia is a common feature of obesity and hypertension and may be associated with abnormal metabolism and
growth of heart muscle and vascular wall. Most of the known actions of insulin were characterised in muscle, adipose tissue and liver. In
this study we investigate the initial steps of insulin signalling in rat heart. Methods: After insulin infusion in the cava vein of male Wistar
rats, the insulin receptor, insulin receptor substrates-1 and -2, phosphatidylinositol 3-kinase activity and Janus kinase (JAK) 2 engagement
were studied by immunoprecipitation and immunoblot of heart extracts. Results: An insulin load induces rapid autophosphorylation of the
insulin receptor which is followed by the phosphorylation of insulin receptor substrates-1 and -2. The phosphorylation of these early
intracellular substrates leads to the association of the p85 subunit of phosphatidylinositol 3-kinase and subsequent activation of its
catalytic p110 subunit. Besides activation of the lipid metabolising enzyme phosphatidylinositol 3-kinase, the phosphorylation of insulin
receptor substrates-1 and -2 engages the intracellular kinase JAK 2 and induces JAK 2–STAT 1 complex formation. Conclusion: We
demonstrate that the early steps of insulin signalling in heart include the phosphorylation–activation of the insulin receptor, engagement
of insulin receptor substrates-1 and -2 with the consequent activation of phosphatidylinositol 3-kinase and the involvement of the recently
discovered growth related pathway—JAK 2–STAT 1. Ó 1998 Elsevier Science B.V. All rights reserved.
Keywords: Insulin receptor; Insulin receptor substrate-1 and -2; Phosphatidylinositol 3-kinase; JAK 2; Heart hypertrophy; Rat
1. Introduction tidylinositol 3-kinase (PI3-kinase), Grb 2, SHPTP2, Nck,
and Fyn, which will extend the insulin signal inwards in
Insulin exerts most of its known actions through a the target cell [4]. Besides IRS-1 and IRS-2 other intracel-
heterotetrameric transmembrane protein tyrosine kinase lular proteins as Shc, ecto-ATPase and pp60 are phos-
receptor (PTKr), the insulin receptor (IR) [1]. Hormone phorylated following insulin treatment [5–7].
binding promotes receptor autophosphorylation and trig- Most of the studies on insulin signalling were performed
gers a cascade of intracellular events that will lead to on tissues that are traditional targets of insulin action such
several metabolic and growth promoting effects [1]. Most as liver, muscle and adipose tissue [1,4]. Those studies
of the early steps of the insulin signalling pathway involve demonstrated that insulin is a pleotropic messenger, and
IR substrates-1 and -2 (IRS-1 and IRS-2), two intracellular many of its actions are tissue specific. Therefore, tissues
docking proteins that undergo tyrosine phosphorylation not traditionally responsive to insulin may potentially
after insulin binding to its receptor [1–3]. The tyrosine suffer some regulation by the hormone. Syndromes of
phosphorylated IRSs proteins bind to several src insulin resistance and hyperinsulinemia are known to
homology-2 (SH2)-containing molecules, such as phospha- coincide with hypertension, obesity and cardiac hyper-
trophy, leading to a condition referred to as Syndrome X
*Corresponding author. Tel.: 155 (19) 239 7734; Fax: 155 (19) 239
3114. Time for primary review 35 days.
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[8,9]. Following clinical and epidemiological observations, amobarbital (100 mg/kg body weight), and the experi-
a pathogenic role for insulin in cardiac disease was ments were performed after the loss of corneal and pedal
proposed [10]. Previous studies attempting to clarify the reflexes. All experiments involving animals were approved
role of hyperinsulinemia upon hypertension and cardiac by the University of Campinas ethical committee.
disease emphasised abnormalities of lipoprotein metabo-
lism and hyperglycemia as possible effectors [10–12]. A 2.4. Tissue extraction, immunoblot and
direct effect of insulin on cardiac and vascular muscle immunoprecipitation
growth have also been proposed [13,14], but little is
known about its molecular basis. In a recent series of In vivo exposition of the heart to isovolumetric (500 ml)
27studies we have shown that angiotensin II (AII) induces solutions containing either insulin (10 M for most of the
IRS-1 and IRS-2 phosphorylation in rat heart [15,16]. experiments, or at the concentration stated in the legends
Moreover, a cross-talk between the insulin and AII sig- of respective figures) or saline were performed by abdomi-
nalling systems modulates PI3-kinase activity and involves nal cava vein injection. The injections were performed in a
the intracellular Janus kinase (JAK) 2 [16]. single dose, as a bolus. A fragment of the tip of the heart
In the present work we investigate the early steps of was excised after 90 s (or as described in time course
insulin signalling in rat heart, including IR autophos- experiments) and immediately homogenised in freshly
phorylation, IRS-1, IRS-2, JAK 2 and STAT 1 engage- prepared, boiling buffer A when intended for immunoblots,
ment, PI3-kinase association to the IRS proteins and its or freshly prepared, ice-cold buffer B when intended for
activation following insulin treatment. immunoprecipitations. Insoluble material was removed by
45 min centrifugation at 50 000 g at 48C. Protein con-
centration in the supernatants was determined by the
2. Methods Bradford method [18].
For immunoprecipitations, samples containing 3 mg of
2.1. Antibodies and chemicals total protein were incubated with 15 ml of antisera antiIRS-
1, -IRS-2, -JAK 2 or -IR at 48C overnight, followed by the
Antisera against IRS-1, IRS-2 and the IR were previous- addition of Protein A Sepharose 6MB for 1 h. The pellets
ly described [3,17]. Antibodies against the p85 subunit of were repeatedly washed in buffer C (five times), resus-
PI3-kinase, against JAK 2 and against STAT 1 were from pended in 50 ml of Laemmli sample buffer [19], and boiled
Santa Cruz (Santa Cruz, CA, USA). Antibodies against for 5 min prior to loading onto the gel. For immuno-
phosphotyrosine were from UBI (Lake Placid, NY, USA). blotting, samples of 150 mg of total protein were sus-125I-protein A was from Amersham (Buckinghamshire, pended in 50 ml of Laemmli sample buffer and boiled for 5
UK). Protein A Sepharose 6MB was from Pharmacia min before loading onto a 6% SDS-polyacrylamide gel(Uppsala, Sweden). Rat liver phosphatidylinositol was electrophoresis (SDS-PAGE) system in a miniature slab
from Avanti Polar Lipids (Milan, Italy). Chemicals were gel apparatus (BioRad, Richmond, CA, USA). Electro-
from Sigma (St. Louis, MO, USA). transfer, blotting and signal detection were as previously
described [20,21].
2.2. Buffers
2.5. PI3-kinase assayBuffer A consisted of 100 mM Tris, 1% sodium dodecyl
sulphate (SDS), 50 mM 4-(2-hydroxyethyl)-1-piperazine-
Aliquots of supernatants of the homogenates intendedethanesulphonic acid (pH 7.4), 100 mM sodium pyro-
for immunoprecipitations, and containing equal amounts ofphosphate, 100 mM sodium fluoride, 10 mM EDTA and
total protein, were incubated overnight at 48C using10 mM sodium vanadate. Buffer B was similar to buffer A
antibodies against IRS-1 or IRS-2. The immunocomplexesexcept that 1% Triton X-100 replaced 1% SDS and 2 mM
were precipitated with Protein A Sepharose 6MB. In vitrophenylmethylsulphonic fluoride and 0.1 mg/ml aprotinin
PI3-kinase assays were performed as described [22].were added. Buffer C contained 100 mM Tris, 10 mM 32Shortly, The P-labelled 3-P-phosphatidylinositol wassodium vanadate, 10 mM EDTA and 1% Triton X-100.
quantified by the Imagequant software of the Phosphor-
Imager (Molecular Dynamics).2.3. Animals
Male Wistar rats (28 day old /90–100 g), bred at the 2.6. Data analysis
animal facilities of the University of Campinas, were used
in the experiments. The rats were allowed free access to Results are presented as direct comparisons of bands
standard rodent chow and water ad libitum. Food was present in fluorographs from insulin treated or saline
withdrawn 12 h before the experiments. The rats were treated rats. When needed, quantification was performed by
anaesthetised by intraperitoneal injection of sodium the Imagequant software of the PhosphorImager (Molecu-
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lar Dynamics). Student’s t-test for paired data was em- One of these proteins is the lipid metabolising enzyme
ployed. PI3-kinase, which is known to be involved in vesicular
trafficking through the cytoplasm, membrane ruffling, and
GLUT 4 translocation towards the cell membrane [4].
3. Results Using specific antibodies we detected, by immuno-
precipitation, IR phosphorylation in heart, following in-
The infusion of insulin in the cava vein of rats induced sulin treatment in vivo. The tyrosine phosphorylated b-
the phosphorylation of proteins present in at least three subunit of the IR migrated at 95 kDa in SDS-PAGE and
bands (185, 135 and 95 kilodaltons (kDa) in total extracts corresponded to the 95 kDa band observed in immunoblots
of heart, separated by SDS-PAGE, and blotted with of total extracts of heart (Fig. 2a). Highest phosphorylation
antiphosphotyrosine antibodies (Fig. 1). The induction of occurred 90 s after insulin injection in the cava vein (n55,
tyrosine phosphorylation was dose dependent, and highest p,0.05 vs. saline treated).
phosphorylation was achieved at insulin concentration of The tyrosine phosphorylation of IRS-1 and IRS-2 was
2710 M (n53, p,0.05 vs. saline treated). Further increase
in insulin concentration led to a slight decrease in protein
tyrosine phosphorylation (Fig. 1a). Using the optimum
27
concentration of 10 M insulin, a time-course experiment
was performed, and after 90 s of infusion in the cava vein
highest phosphorylation was detected (Fig. 1b).
The traditional pathway of insulin signalling in liver,
muscle and adipose tissue involves the phosphorylation
and activation of the transmembrane IR, the phosphoryla-
tion of two intracellular docking proteins, IRS-1 and IRS-
2, and the engagement of several SH2 containing proteins.
Fig. 1. Autoradiograms of antiphosphotyrosine immunoblots of rat heart Fig. 2. Autoradiograms of immunoblots of rat heart immunoprecipitates
27total extracts resolved in 6.5% SDS-PAGE. (a) Dose–response of tyrosine resolved in 6.5% SDS-PAGE. Five hundred ml of 10 M insulin or
phosphorylated proteins of the heart exposed to increasing concentrations saline (as depicted in the upper margins) were injected though the cava
of insulin injected through the cava vein. A tip of the heart was excised vein and after 90 s the hearts were excised and homogenized. Immuno-
90 s after insulin or saline injection (as depicted in the upper margin of precipitations were performed using antiIR (a), antiIRS-1 or antiIRS-2 (b
the figure) (n53). (b) Time course of insulin-stimulated phosphorylation and c) antibodies. Blots were performed using antiphosphotyrosine
27
of proteins in rat heart. Five hundred ml of 10 M insulin was injected antibodies (a and b). Membranes from IRS-1 and IRS-2 immuno-
though the cava vein and a tip of the heart was excised after the elapsed precipitates blotted with antiphosphotyrosine antibodies were stripped and
time (as depicted in the upper margin of the figure) (n53). Molecular reblotted with antip85 antibody (c) (n55). Molecular mass standards are
mass standards are depicted in the left-hand margin. depicted in the left-hand margins.
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detected in immunoprecipitation experiments. Thus, 90 s with activators of transcription known as STATs. In THE
27
after the injection of 500 ml of 10 M insulin, tyrosine heart of rats we observed that the treatment with 500 ml of
27phosphorylated IRS-1 and IRS-2 could be captured in 10 M insulin induced the association of JAK 2 with
immunoprecipitation experiments using specific antibodies, STAT 1 (Fig. 4d) (n54, p,0.05 vs. saline treated).
and detection was performed by separation in SDS-PAGE
and blotting with antiphosphotyrosine antibodies (Fig. 2b).
The association of the p85 subunit of PI3-kinase with the 4. Discussion
phosphorylated IRS-1 and IRS-2 was demonstrated by
stripping nitrocellulose membranes of IRS-1 and IRS-2 In the present study we show that in rat heart, rapidly
immunoprecipitates and reblotting with antip85 antibodies after insulin stimulation, the b-subunit of the IR undergoes
(Fig. 2c). The insulin-induced association of the p85 autophosphorylation. As a consequence both IRS-1 and
subunit of PI3-kinase with IRS-1 and IRS-2 led to a dose IRS-2 are as well phosphorylated. Following phosphoryla-
dependent activation of the lipid metabolising enzyme. tion both IRS-1 and IRS-2 bind to and activate, in a dose
27Thus, after a 500 ml load of 10 M insulin in the cava dependent manner, the lipid metabolising enzyme PI3-
vein a complex containing maximal activity of PI3-kinase kinase. Moreover, the intracellular kinase JAK 2 is co-
towards the substrate phosphatidylinositol could be pre- precipitated with IRS-1 and IRS-2 and phosphorylated in
cipitated together with IRS-1 (Fig. 3a) and IRS-2 (Fig. 3b) response to insulin stimulation. The insulin-induced JAK 2
(n53, p,0.05 vs. saline treated). phosphorylation leads to JAK 2–STAT 1 complex forma-
The activation of cellular growth promoting pathways tion and directs the insulin signal towards the nucleus.
by insulin have been described in tissues such as liver, The insulin-stimulated increase in IRS-1 and IRS-2
muscle and adipose tissue [1]. Although in those tissues associated PI3-kinase activity correlated with insulin
the activation of metabolic related pathways is predomi- stimulation of tyrosine phosphorylation of IRS-1 and IRS-
nant, the engagement of Shc, Grb, the downstream MAP 2, and the IR b-subunit. When the data of IR b-subunit,
kinase cascade and JAK 2 have been fully observed [1,4]. IRS-1 and IRS-2 phosphorylation and PI3-kinase associ-
To investigate whether in heart JAK 2 is engaged after ated activity from a dose–response experiment in heart are
insulin treatment, we performed immunoprecipitation ex- expressed as a percentage of maximal stimulation, a close
periments using a specific JAK 2 antiserum. The injection correlation between these parameters is apparent. The
27
of 500 ml of 10 M insulin induced the phosphorylation ED values for these parameters were 0.4 mg for IRS-150
of JAK 2 (Fig. 4a) (n54, p,0.05 vs. saline treated). and IRS-2 phosphorylation, 0.5 mg for PI3-kinase activity
Striping and reblotting of nitrocellulose membranes re- and 0.8 mg for the IR b-subunit phosphorylation. The
vealed the insulin-induced association of JAK 2 with acute half-maximal stimulation of PI3-kinase in heart
IRS-1 (Fig. 4c) and IRS-2 (not shown). The amount of occurred at a plasma insulin concentration which is
JAK 2 captured by the immunocomplex was similar in achieved in normal rats during a meal tolerance test or an
heart immunoprecipitates from insulin-treated and non- oral glucose tolerance test (data not shown). Thus, our
insulin-treated rats (Fig. 4b). The mitogenic activity of results show that there is a significant increase in PI3-
JAK 2 is carried towards the nucleus by its association kinase activity at concentrations of insulin which are
needed to regulate glucose disposal by the heart in intact
rats. Distinct experimental approaches coming from differ-
ent tissues or cell culture have demonstrated a correlation
between PI3-kinase activity and glucose transport, and also
of PI3-kinase activity and glycogen metabolism [1]. Tak-
ing together these results, and the data herein presented,
we believe that the IRS-1/ IRS-2–PI3-kinase associated
pathway may be linked to the activation of glucose
transport and glycogen synthesis in the heart.
During the last 10 years the cardiovascular effects of
insulin were emphasised and insulin resistance /hyperin-
sulinemia have been implicated in hypertension and
atherosclerosis. A higher than expected frequency of
myocardial hypertrophy occurs in some genetic insulinFig. 3. Autoradiograms of silica TLC plates of IRS-1 (a) and IRS-2 (b)
associated PI3-kinase activity. Five hundred ml of saline or insulin (as states and also in acquired forms of insulin resistance
depicted in the upper margins) were injected through the cava veins of [8,9,23,24]. Although these associations are difficult to
rats and after 90 s the hearts were excised and homogenized. Immuno- explain, they may result, at least in part, from the
precipitations were performed using antiIRS-1 (a) and antiIRS-2 (b) hyperinsulinemia that occurs in the majority of patients.
antibodies, and PI3-kinase activity assay was performed as described in
The pathways used by hyperinsulinemia to induce myocar-Section 2 (n53). The arrow indicates the migration site of PI3-P
(phosphatidylinositol 3-phosphate). dial hypertrophy are not known but some recent data on
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27Fig. 4. Autoradiograms of immunoblots of rat heart immunoprecipitates resolved in 6.5% SDS-PAGE. Five hundred ml of 10 M insulin or saline (as
depicted in the upper margins) were injected though the cava vein and after 90 s the hearts were excised and homogenized. Immunoprecipitations were
performed using antiJAK 2 antibodies. Tyrosine phosphorylated proteins associated to JAK 2 and stimulated by insulin were detected by blotting
nitrocellulose membranes with antiphosphotyrosine antibodies (a). The membranes were stripped and reblotted with antiJAK 2 antibodies (b), antiIRS-1
antibodies (c) and antiSTAT 1 antibodies (d) (n54). Molecular mass standards are depicted in the left-hand margin.
transgenic models of insulin resistance [25–27] and our signalling pathway occurs directly through their own
present results may contribute to formulation of an initial receptors and early substrates, as the receptors have
characterisation of these effects. Our results showing that intrinsic tyrosine kinase activity [29,30]. However, mem-
insulin is able to induce JAK 2 tyrosine phosphorylation in bers of the G-protein-coupled receptor family and
heart is of interest, since JAK 2 is involved in growth cytokine-1 receptor family require a kinase to mediate the
promoting pathways stimulated by different peptides interaction. Several pieces of evidence demonstrate that
[16,27,28]. members of the JAK family are engaged in the cross-talk
Recently, several reports have demonstrated complex between many of these signalling pathways [16,27,28].
intracellular interactions between the insulin signalling Our results, showing that insulin stimulates JAK 2 phos-
pathway and other hormone signalling systems. Thus, phorylation and STAT 1 association, may contribute to
IGF-1 and IL-4 acting through PTKr require IRS-1 for further characterisation of the cross-talk between insulin-
their downstream signalling and potentially modify the and other hormone-signalling pathways in heart.
insulin signal [29,30]. Moreover, AII and epinephrine The findings described herein show a direct effect of
acting through G-protein-coupled receptors may modify or insulin in heart with engagement of early responsive
have their signals modified by insulin [16,31]. Finally, elements involved in the insulin signalling pathway. The
growth hormone, erythropoietin and IL-9, acting through signal is started by the rapid phosphorylation of the IR
members of the cytokine-1 receptor family interact with which induces the phosphorylation of its two major
the insulin signalling pathway [27,28,32]. The interaction intracellular substrates, IRS-1 and IRS-2. Following phos-
of members of the IGF-1 receptor family and the insulin phorylation, both IRS-1 and IRS-2 may be co-precipitated
D
ow
nloaded from
 https://academ
ic.oup.com
/cardiovascres/article-abstract/40/1/96/533343 by U
niversità degli Studi di M
ilano user on 04 Septem
ber 2019
L.A. Velloso et al. / Cardiovascular Research 40 (1998) 96 –102 101
Fig. 5. Summary of findings of the present and previous ( [15,16]) studies on insulin signalling in rat heart. The activation of the insulin receptor by insulin
binding leads to IRS-1 and IRS-2 phosphorylation. Once phosphorylated IRS-1/2 bind to and activate PI3-kinase which directs the signal towards glycogen
metabolism and stimulation of glucose transport. Moreover, phophorylated IRS-1/2 engages JAK 2 leading to STAT 1 activation and nuclear signalling. A
role for JAK 2 on intracellular cross-talk is proposed. EC, extracellular; IC, intracellular.
phosphorylation of a M 185 000 protein in intact cells. Naturewith the p85 subunit of the lipid metabolising enzyme r
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